Episodes
Editor-in-Chief, Dr Lan-Lan Smith, speaks with Dr Judith Boer (Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands) about outcome of ABL-class acute lymphoblastic leukaemia in children in the pre-tyrosine kinase inhibitor era.
Published 12/22/20
Andrea Biondi joins The Lancet Haematology to discuss his work on imatinib as a treatment for paediatric Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Published 12/15/18
Prashant Hiwarkar joins The Lancet Haematology to discuss his new paper, an investigation into whether serial faecal PCR monitoring can predict the risk of adenoviraemia and survival outcomes after HSCT.
Published 08/31/18
Lead author Gita Thanarajasingam joins The Lancet Haematology to discuss the new Commission on assessment and adverse event reporting in haematological malignancies.
Published 06/12/18
Jules Heuberger talks about his study on the effectiveness of EPO use by cyclists.
Published 06/30/17
Petra Innerhofer discusses reversal of trauma-induced coagulopathy using first-line coagulation factor concentrates or fresh frozen plasma.
Published 06/03/17
Audrey Bonaventure discusses her CONCORD-2 study, monitoring survival trends of two types of childhood leukaemia in 53 countries between 1995 and 2009.
Published 04/12/17
Jan Beyer discusses the SURPRISE trial of patients developing complications from superficial-vein thrombosis.
Published 02/16/17
Dr Jose Leal discusses a study of the costs related to malignant and non-malignant blood disorders in Europe in 2012.
Published 07/21/16
David Fajgenbaum discusses a literature review to raise awareness of idiopathic multicentric Castleman disease, a poorly understood haematological disorder.
Published 03/18/16
Walter Ageno discusses the use of an algorithm combining limited and whole-leg compression ultrasonography to diagnose deep-vein thrombosis.
Published 10/30/15
Scott Huntington discusses the financial toxicity of oncology treatments
Published 09/17/15
James Bussel discusses a study looking at treatment options for children facing idiopathic thrombocytopenic purpura.
Published 07/29/15
Klervi Leuraud discusses a study reporting on the risk of developing leukaemia and lymphoma in workers monitored for radiation exposure.
Published 06/29/15
Páll Önundarson describes a new method for monitoring clotting in patients treated with warfarin, which they tested in a non-inferiority, randomised clinical trial.
Published 05/26/15
Mahmoud Zureik discusses risk of bleeding in patients with non-valvular atrial fibrillation who switched and those who remained on a vitamin K antagonist.
Published 04/02/15
Dietger Niederwieser and Richard Lane discuss the journey to 1 million haematopoietic stem cell transplantations.
Published 02/27/15
Guillermo Garcia-Manero discusses a phase 1/2 study on sequential azacitidine and lenalidomide in high-risk MDS and AML.
Published 01/07/15
Gregory Kato discusses a phase I study for the treatment of leg ulcers for people with sickle-cell disease.
Published 12/02/14